The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK has implemented the International Recognition Procedure (IRP) starting January 1, 2024.
The IRP is designed to streamline the registration of pharmaceutical products in the UK by considering the expertise and decision-making of trusted regulatory partners who have already authorised the product. The countries and regions covered by this procedure include Australia, Canada, the European Union, Japan, Switzerland, Singapore, and the United States.
The introduction of the IRP marks a significant milestone in the UK’s post-Brexit strategy for approving medicines. The IRP is a strategic response to the dynamic global environment of life sciences and medicine advancement, aiming to maintain the UK’s appeal as a focal point for pharmaceutical innovation and to guarantee patient access to cutting-edge treatments.
๐๐ก๐ ๐๐๐จ๐ฉ๐ญ๐ข๐จ๐ง ๐จ๐ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฅ๐ข๐๐ง๐๐ ๐ฉ๐ซ๐จ๐๐๐๐ฎ๐ซ๐ ๐ข๐ฌ ๐๐ง๐ญ๐ข๐๐ข๐ฉ๐๐ญ๐๐ ๐ญ๐จ ๐๐ง๐ก๐๐ง๐๐ ๐ญ๐ก๐ ๐ฉ๐๐๐ ๐๐ง๐ ๐๐๐๐๐๐ญ๐ข๐ฏ๐๐ง๐๐ฌ๐ฌ ๐จ๐ ๐๐ฏ๐๐ฅ๐ฎ๐๐ญ๐ข๐ง๐ ๐ง๐๐ฐ ๐ฆ๐๐๐ข๐๐ข๐ง๐๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐. ๐๐๐ฏ๐๐ซ๐๐ ๐ข๐ง๐ ๐๐ฑ๐ข๐ฌ๐ญ๐ข๐ง๐ ๐๐ฉ๐ฉ๐ซ๐จ๐ฏ๐๐ฅ๐ฌ ๐๐ซ๐จ๐ฆ ๐ซ๐๐ฅ๐ข๐๐๐ฅ๐ ๐ซ๐๐ ๐ฎ๐ฅ๐๐ญ๐จ๐ซ๐ฒ ๐๐จ๐ฅ๐ฅ๐๐๐จ๐ซ๐๐ญ๐จ๐ซ๐ฌ, ๐ญ๐ก๐ ๐๐๐ ๐ฌ๐ญ๐ซ๐ข๐ฏ๐๐ฌ ๐ญ๐จ ๐๐ฑ๐ฉ๐๐๐ข๐ญ๐ ๐ญ๐ก๐ ๐๐ฏ๐๐ข๐ฅ๐๐๐ข๐ฅ๐ข๐ญ๐ฒ ๐จ๐ ๐ฌ๐๐๐ ๐๐ง๐ ๐๐๐๐ข๐๐๐๐ข๐จ๐ฎ๐ฌ ๐ฆ๐๐๐ข๐๐ข๐ง๐๐ฌ ๐๐จ๐ซ ๐ฉ๐๐ญ๐ข๐๐ง๐ญ๐ฌ ๐ข๐ง ๐ญ๐ก๐ ๐๐.
Sources:
- International Recognition Procedure. United Kingdom: Medicines and Healthcare products Regulatory Agency. Dec 20 2023. Available from: https://www.gov.uk/government/publications/international-recognition-procedure/international-recognition-procedure (Accessed 04 Jan 2024)
- Medicines and Healthcare products Regulatory Agency. MHRA’s new International Recognition Procedure (IRP) goes live from 1 January 2024. GOV.UK. Jan 2 2023. Available from: https://www.gov.uk/government/news/mhras-new-international-recognition-procedure-irp-goes-live-from-1-january-2024 (Accessed 04 Jan 2024)